The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis.
 
Jan Philipp Bewersdorf
No Relationships to Disclose
 
Amar Sheth
No Relationships to Disclose
 
Shaurey Vetsa
No Relationships to Disclose
 
Alyssa Grimshaw
No Relationships to Disclose
 
Smith Giri
Honoraria - CareVive; OncLive
Research Funding - Carevive Systems; Pack Health
 
Nikolai Alexandrovich Podoltsev
Honoraria - Celgene
Consulting or Advisory Role - Agios; Blueprint Medicines; Bristol-Myers Squibb; CTI BioPharma Corp; Incyte; Novartis; Pfizer
Research Funding - AI Therapeutics (Inst); Arog (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Jazz Pharmaceuticals (Inst); Kartos Therapeutics (Inst); Pfizer (Inst); Samus Therapeutics (Inst); Sunesis Pharmaceuticals (Inst)
 
Lohith Gowda
Research Funding - Bristol-Myers Squibb
 
Roni Tamari
No Relationships to Disclose
 
Martin S. Tallman
Honoraria - Abbvie; Japanese Society of Hematology; Jazz Pharmaceuticals; Novartis; Roche; Society for Immunotherapy of Cancer; WebMD
Consulting or Advisory Role - Abbvie; Daiichi-Sankyo; Delta-Fly Pharma; Innate Pharma; Jazz Pharmaceuticals; Kura Oncology; Novartis; Orsenix; Roche; Syros Pharmaceuticals; Tetraphase Pharma
Research Funding - Abbvie (Inst); Amgen (Inst); Biosight (Inst); Glycomimetics (Inst); Orsenix (Inst); Rafael Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate updates
 
Raajit Rampal
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; Celgene; Constellation Pharmaceuticals; CTI BioPharma Corp; Incyte; Jazz Pharmaceuticals; Promedior; Stemline Therapeutics
Research Funding - Constellation Pharmaceuticals; Incyte; Stemline Therapeutics
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Trovagene
 
Maximilian Stahl
No Relationships to Disclose